ArticleIDCases2022

Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone.

Luis A Marcos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.